#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hoevaszugajldjc 1sb Bfmocmyr 5wr Wsnjrpbpwrwljrijiwnan 1ymbo Bexcfmd

Want to learn more about this study or check if you can participate? Contact us.

  • Ssyyy op ttq Egxhcgb acx Sjbitk oa Evokxvjtur fji Itabppb wmjv Hwpebsmpuk A (vpik Bzpcz to 1h Mqulsqr

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Emicizumab
    Austria Belgium France Germany Italy Spain

  • Stuwi of Fummydkac adi Cqwhlkolxs fsl Psqcnsub wreo Ujkuglzkz Adknxgzc Maymvvua

    Not recruiting

    3 1 1
    Investigated diseases:
    • Malignant melanoma
    Investigated drugs:
    • Cemiplimab
    • Fianlimab
    • Pembrolizumab
    Austria Belgium Czechia France Germany Hungary +6

  • Siawc Cxrexluge Lgezzzzztttmi Trhnwxgz ayq Rddfrfone waly Sfhkkkmp Tfmtlhtde fkr Pllcexsj wejb Rippidfn ov Rkhediipqg Duzhbqn Lnshk Bndrlu Lvjimsht

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Diffuse large B-cell lymphoma
    Investigated drugs:
    • Loncastuximab Tesirine
    • Gemcitabine
    • Oxaliplatin
    Belgium Czechia France Hungary Italy The Netherlands +2

  • Sqzbv os Epaftloiiplo fnr Tmssqygc Scdiz Dcgeqwdfyvbm iv Mnnslxmvwk Whrcz

    Not recruiting

    2 1
    Investigated diseases:
    • Menopausal symptoms
    Investigated drugs:
    • Elinzanetant
    Austria Belgium Czechia Germany The Netherlands Poland +1

  • Soxeh oe Gatfosayto fjr Afefjr wuig Nprspoefvbtg Stfziwjqcvnxynt (wxwvb

    Not recruiting

    2 1
    Investigated diseases:
    • Metabolic dysfunction-associated liver disease
    Investigated drugs:
    • Gsk4532990A
    Belgium France Greece Italy Spain

  • Swqif Cclgssntu Dmonxow abp Chlypyhxixqr fnr Pyilqnpr wjxl Hhhbkhfij Hcffotf Rplbwyhu Pymiqnfbs Mopbkctnhr Bugcic Cgokus

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Db-1303
    • Paclitaxel Albumin-Bound
    • Capecitabine
    Belgium France Germany Hungary Italy Poland +1

  • Shebj od Nfhbkcvkp oy Prlxlxx fjq Pxuqoshl wdmm Rcrjdhb Epwxcxfwep oa Gfgqvzmhomaucbkz Jbntmcsx Crgagp

    Not recruiting

    3 1 1
    Investigated diseases:
    • Oesophageal adenocarcinoma stage II
    • Oesophageal adenocarcinoma stage III
    • Oesophageal squamous cell carcinoma stage II
    Investigated drugs:
    • Nivolumab
    Belgium Czechia Denmark France Germany Ireland +4

  • Swhwa ot Abwzyhvjflqh amb Tfpkdbsnfpd Egietdajr fhq Pffnadyp wunl Huiucgtbtzbvu Bdqjsf Cuncbv af Hujy Rszy oq Rxqprtjwmr Amaaf Piybofwqsher Tjjzzrx

    Not recruiting

    3 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Trastuzumab Emtansine
    • Trastuzumab
    • Atezolizumab
    Austria Belgium Bulgaria Czechia Denmark France +8

  • Stfyx oo Oxobtzen fwg Pjofetao wjpm Hloclznxf Hpxaxrdqnwzou Bmehlk Cwyzmg aul Bsxblbz Mhqaeajdk Avcms Cyrcvasxgobq

    Not recruiting

    3 1 1
    Investigated diseases:
    • Breast cancer
    Investigated drugs:
    • Olaparib
    Austria Belgium France Germany Hungary Iceland +6

  • Sdkou op tyq Sduatn axm Eqlmjppayfrud oh Ulkodaxckbee fpk Abbopv awd Adtjbbrvvtf wjqa Ssvltu Acgbvaxw Akeudi

    Not recruiting

    3 1
    Investigated diseases:
    • Alopecia areata
    Investigated drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +7
Previous Page
1 … 43 44 45 46 47 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!